Evaluation of agreement between clinical and histopathological data for classifying leprosy

Victor Santana Santos, Pedro Teles de Mendonça Neto, Oscar Felipe Falcão Raposo, Ricardo Fakhouri, Francisco Prado Reis, Vera Lúcia Corrêa Feitosa

International Journal of Infectious Diseases · 2012 · 32 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

Leprosy is a chronic infectious granulomatous disease with a prolonged incubation period that affects the skin and peripheral nerves. It is caused by Mycobacterium leprae, which parasitizes macrophages and Schwann cells. nnually, approximately 200 000 people are affected throughout the world. The highest detection rates are found in developing countries located in Southeast Asia, Africa, and South America. In 2010, Brazil was the country with the second highest number of cases in the world, only behind India. eprosy has a variety of clinical, microbiological, and pathological findings, and it is diagnosed based mainly on the presence of skin lesions, loss of sensitivity, and neural thickening. The various clinical presentations are determined by the different levels of cellular immune response to M. leprae, 1,2,4 which are expressed through different pathophysiological mechanisms, with particular signs, symptoms, progression, prognosis, and contagion that have allowed numerous classifications. However, these classifications present important differences regarding sensitivity and specificity, and thus require critical analysis for their application, especially in regions that are considered endemic. he classification proposed by Rabello at the International Leprosy Congress in Madrid in 1953, took into account clinical data and the characteristics of skin lesions presented by patients by dividing them into spectral forms: indeterminate (I), tuberculous (T), dimorphic (D), and lepromatous (L). n 1966, Ridley and Jopling introduced a classification system based on histopathological findings and on the level of cellular immunity. 9 From these criteria, leprosy patients were divided into five groups: tuberculoid (TT), borderline tuberculoid (BT), midborderline (BB), borderline lepromatous (BL), and lepromatous

References

18